GridAI Technologies Corp. filed a Form S-8 registration statement with the SEC on October 26, 2026, to register an additional 3,690,190 shares of common stock under its 2020 Omnibus Equity Incentive Plan, as amended and restated, pursuant to the plan's evergreen provision.

Key Highlights

  • Shares registered: 3,690,190 additional shares of common stock, par value $0.0001 per share, added under the 2020 Omnibus Equity Incentive Plan.
  • Evergreen provision: The increase in available shares is made pursuant to the plan's evergreen provision, according to the filing.
  • Allocation breakdown: Of the 3,690,190 shares, 1,386,032 are reserved for future awards and 2,304,158 are covered by an included reoffer prospectus.
  • Reoffer prospectus: Up to 2,304,158 shares may be reoffered or resold by certain Selling Stockholders, described as executive officers, directors, and consultants who may be deemed affiliates.
  • Resale limitation: Because the company does not currently satisfy registrant requirements for Form S-3, each Selling Stockholder's resales may not exceed, during any three-month period, the amount specified in Rule 144(e) under the Securities Act.
  • Closing price: On October 23, 2026, the closing price of the common stock on the Nasdaq Capital Market was $5.605 per share, as stated in the filing.
  • No proceeds to company: The filing states the company will not receive any proceeds from sales of shares by Selling Stockholders.

GridAI Technologies Adds Shares to Equity Plan via Evergreen Provision

GridAI Technologies Corp. (NASDAQ:GRDX), formerly known as Entero Therapeutics, Inc., filed a Form S-8 registration statement on October 26, 2026, to register 3,690,190 additional shares of its common stock, par value $0.0001 per share, under its 2020 Omnibus Equity Incentive Plan, as amended and restated. According to the filing, the plan was originally approved by the board of directors and stockholders and took effect on September 11, 2020. The current registration is triggered by the plan's evergreen provision, which allows for periodic increases in the shares available for issuance.

The filing discloses that of the 3,690,190 newly registered shares, 1,386,032 are reserved for future awards under the plan, while the remaining 2,304,158 shares are covered by a reoffer prospectus included within the registration statement. The reoffer prospectus permits certain Selling Stockholders, including executive officers, directors, and consultants who may be considered affiliates of the company, to resell shares acquired or to be acquired under the plan. The filing notes that the company does not currently satisfy the registrant requirements for use of Form S-3, and accordingly, resales by each Selling Stockholder via the reoffer prospectus may not exceed, during any three-month period, the amount specified in Rule 144(e) under the Securities Act.

The filing also references three previously effective Form S-8 registration statements: filed April 4, 2023 (Registration No. 333-271124), August 21, 2023 (Registration No. 333-274118), and June 24, 2024 (Registration No. 333-280430), which together covered 111,359 shares of common stock under the same plan. The information from those prior statements is incorporated by reference into this filing. The company states it will not receive any proceeds from Selling Stockholder resales of the shares covered by the reoffer prospectus.

What Was Disclosed

GridAI Technologies Corp. registered 3,690,190 additional shares under its 2020 equity incentive plan via a Form S-8, splitting the total between future award reserves and a reoffer prospectus for certain affiliates, with no proceeds to the company from any Selling Stockholder resales.